The first batch of Pfizer BioNTech vaccine arrived in Taiwan on Thursday morning, according to health officials. After months of struggling to get the BioNTech vaccine on the island, 930,000 doses were given.
In May, President Tsai Ing-wen attributed this delay to “China’s intervention.”
Fosun Pharma, a Chinese company, has claimed exclusive commercial rights to the distribution of BioNTech vaccines in Taiwan. In Taiwan, cold relations with China have strengthened in recent months. Two Taiwanese megacorporations, a charity and a Buddhist foundation, set foot in the quagmire in July and provided a solution.
Foxconn, Apple’s leading iPhone assembler, and TSMC, which manufactures chips found on Apple devices, have agreed with the Yonglin Foundation, a charity founded by the founders of Foxconn, to deliver 10 million BioNTech vaccines from Fosun Pharma. I bought it. Donate them to the Taiwanese government. The Buddhist organization Tzu Chi has agreed to purchase and donate an additional 5 million BioNTech shots from a Chinese company for vaccination activities in Taiwan.
Earlier this week, the Taiwan Centers for Disease Control and Prevention issued a statement announcing that the BioNTech vaccine will be given priority to people aged 12 to 17 years and the remaining doses will be given to people aged 18 to 22 years.